GlassScriptPhysician profile
Suzanne Hartmann
NPI 1558617134
$12,467.00
in general payments reported to CMS, 2019-2025
60 companies · $2,681 in 2025
The $2,681 reported for 2025 was more than what 97% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,586 · 2022: $2,368 · 2023: $2,720 · 2024: $3,112 · 2025: $2,681.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,512.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,773.44 | 2021-2025 | |
| Ucb, INC. | $1,075.53 | 2022-2025 | Briviact, Nayzilam, Rystiggo |
| Lundbeck LLC | $712.83 | 2022-2025 | Vyepti |
| Mdd US Operations, LLC | $648.48 | 2021-2025 | Gocovri, Gocovri |
| Teva Pharmaceuticals USA, INC. | $585.19 | 2021-2025 | Austedo Xr, Austedo, Ajovy |
| Pfizer INC. | $575.88 | 2023-2025 | |
| Neurocrine Biosciences, INC. | $441.55 | 2022-2025 | Ingrezza, Ongentys |
| Novartis Pharmaceuticals Corporation | $407.49 | 2021-2025 | |
| Amgen INC. | $399.69 | 2021-2025 | Uplizna, Aimovig |
| Eisai INC. | $389.30 | 2021-2025 | |
| Impel Pharmaceuticals INC. | $363.58 | 2022-2023 | Trudhesa |
| Alexion Pharmaceuticals, INC. | $334.96 | 2021-2025 | Ultomiris, Soliris |
| Biogen, INC. | $318.26 | 2021-2025 | Leqembi, Vumerity, Tysabri |
| Genzyme Corporation | $197.16 | 2021-2022 | |
| Merz Pharmaceuticals, LLC | $195.24 | 2023-2025 | Xeomin, Inbrija |
Show all 60 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Hartmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.